Skip to main content

Verified by Psychology Today

Eating Disorders

Relationships Between Schizophrenia and Eating Disorders

These disorders can coexist, but why is unclear.

Key points

  • Schizophrenia is a psychological illness that includes delusions, hallucinations, and disorganized thinking.
  • Eating disorders are psychological illnesses that include disordered eating and perceived body distortions.
  • There are no definitive conclusions for why some people develop both an eating disorder and schizophrenia.
Sasha Freemind/Unsplash
Source: Sasha Freemind/Unsplash

Schizophrenia is a psychological illness that includes positive (e.g., delusions and hallucinations) and negative (e.g., apathy and social withdrawal) signs and symptoms, as well as cognitive impairment (e.g., disorganized thinking).1

Roughly 1 in 300 people (3%) worldwide are diagnosed with schizophrenia2 and, while causes for schizophrenia are unclear, a genetic predisposition,1 coupled with environmental factors (e.g., adverse experiences during childhood; infection)3, likely contribute to its development.1

While schizophrenia is not as prevalent as other psychological disorders (e.g., anxiety), the detrimental impact it can have on a person's life is substantial (e.g., family; social; workplace).4 And, schizophrenia can co-occur with additional disorders (e.g., panic disorder; posttraumatic stress disorder; obsessive-compulsive disorder; depression; substance abuse; eating disorders)5;6, putting an even greater strain on quality of life for these individuals.

Eating Disorders and Schizophrenia

Artem Labunsky/Unsplash
Source: Artem Labunsky/Unsplash

Most people with schizophrenia do not meet the full clinical criteria for an eating disorder diagnosis.7 Nonetheless, across different research studies, roughly 0.081% to 4% of men and women diagnosed with schizophrenia report anorexia nervosa (AN) signs/symptoms, 0.73% to 3.7% report bulimia nervosa (BN) signs/symptoms, 5.9% to 12.1% report binge eating disorder (BED) signs/symptoms, 8% report night eating syndrome (NES) signs/symptoms, and 30% report nonspecific disordered eating signs/symptoms.7

Schizophrenia is more common in men than in women and, unsurprisingly, men are more likely to have simultaneous signs/symptoms of both an eating disorder and schizophrenia compared with women.7 For example, on average, men are 3.6 times more likely to have cooccurring signs/symptoms of AN and schizophrenia compared with women.7

While extreme psychosis in eating disorders is uncommon, psychosis symptoms frequently occur in association with eating disorder signs/symptoms.8 For example, a recent research study found that university students who report lifetime psychosis symptoms, as well as psychosis symptoms within the past 12 months, are more likely to screen positive for an eating disorder compared with students without previous experiences with psychosis.9

Explanations for Relationships Between Eating Disorders and Schizophrenia

The coexistence of schizophrenia and eating disorders could be unrelated, as the two disorders might develop independently.6 From this perspective, people with schizophrenia have a similar likelihood of developing an eating disorder compared with the general population.

There is evidence, however, that one of these disorders might contribute to the development of the other.6 Which disorder is typically observed first, though, is unclear and likely varies across individuals.6 For example, in several case reports of men with an eating disorder, the eating disorder preceded patients' schizophrenia diagnosis.10 In other cases, though, schizophrenia preceded eating disorder signs/symptoms.10

One explanation for why schizophrenia could contribute to the development of an eating disorder is the prodromal phase of schizophrenia, which occurs before the presence of psychosis in schizophrenia. During the prodromal phase of schizophrenia, people experience anxiety and depression,11 which can contribute to eating disorder development.12 In fact, Malaspina et al (2019) argue that eating disorder signs/symptoms could indicate the beginning stages of schizophrenia development.13 In these cases, disordered eating might reduce over the course of schizophrenia treatment.

Uday Mittal/Unsplash
Source: Uday Mittal/Unsplash

It's also possible that psychosis in schizophrenia contributes to the development of restrictive eating, as schizophrenia-related delusions might include paranoia over contaminated or poisoned food.6 Psychosis in schizophrenia could also contribute to body self distortions (i.e., difficulties perceiving and interpreting body experiences, like hunger).14 Difficulties interpreting hunger and fullness cues in schizophrenia could contribute to the development of an eating disorder.

An eating disorder might also contribute to schizophrenia-like symptoms. For example, psychosis could be the result of starvation or electrolyte and metabolic imbalances in people with clinical AN—in these cases, psychosis symptoms might disappear following AN remission.6 Restrictive eating might also be a way for people with AN and/or schizophrenia to gain a perceived sense of control over their lives, which is often lacking in people with either of these illnesses.6

People with schizophrenia and/or eating disorders also share common genetic variants that increase vulnerability for developing both disorders, with environmental factors contributing to the onset of either illness.6;15;16 For example, research shows that dopamine genes are dysregulated in people diagnosed with schizophrenia and/or an eating disorder and those who have a family history of either of these disorders.17;18

The Role of Antipsychotics in Eating Disorder Symptoms in People With Schizophrenia

Alexander Grey/Unsplash
Source: Alexander Grey/Unsplash

Atypical levels of certain brain chemicals (i.e., dopamine; serotonin) are one explanation for psychosis symptoms in schizophrenia.19 The most effective treatment for schizophrenia, therefore, is second-generation antipsychotics (SGAs).20;21 SGAs are medications that lower dopamine and serotonin levels in the brain. By lowering these brain chemicals, antipsychotics help prevent relapse and rehospitalization for people with schizophrenia.

While SGAs are essential for schizophrenia treatment, these drugs have side effects that could contribute to the development of an eating disorder. For example, side effects of some SGAs are compulsive eating, food cravings, weight gain, and/or body image distortions.22;23;24 In this way, the use of SAGs in schizophrenia treatment could contribute to the development of BN or BED.25;26

The brain mechanics of how SGAs influence eating behavior and body metabolism are not entirely understood. We do know that, once in the body, SGAs attach to multiple types of dopamine and serotonin receptors in the brain, which reduces the amount of these chemicals in the brain.27 These chemical changes can have a profound impact on eating behavior. For example, rodent research has shown that SGAs bind to serotonin 2C receptors—the effects of these interactions reduce serotonin in the brain, which increases food intake and contributes to weight gain in rodents.28 These effects make sense given that serotonin reduces appetite and, therefore, decreases in serotonin could increase appetite. The effects of SGAs on food intake are complex, though, and likely involve multiple brain receptors that vary across different SGA types (e.g., clozapine; risperidone).29


While relationships between schizophrenia and eating disorders are unclear, evidence shows that signs and symptoms of each disorder can overlap. Health professionals, therefore, need to consider the best ways to manage co-occurring signs and symptoms of both disorders—these approaches will vary from person to person, with the common goal of improving patient quality of life.

Acknowledging the potential side effects of SGAs in schizophrenia, such as increased appetite and weight gain, are also important for patient well-being. A potential preventative measure for eating disorder development in people with schizophrenia is to provide these individuals with a therapist and/or nutritionist as part of their treatment plan. It might also be necessary to adjust patient dosages of SGAs to reduce side effects that could contribute to eating disorder development.

To find a therapist, please visit the Psychology Today Therapy Directory.


1) McCutcheon, R.A., MRCPsych, Marques, T.R., & Howes, O.D. (2020). Schizophrenia - An overview. JAMA Psychiatry, 77, 201-210. doi:10.1001/jamapsychiatry.2019.3360.

2) World Health Organization. (2022). Schizophrenia. World Health Organization. Retrieved from:

3) Robinson, N., & Bergen, S.E. (2021). Environmental risk factors for schizophrenia and bipolar disorder and their relationship to genetic risk: Current knowledge and future directions. Frontiers in Genetics, 12.

4) Narvaez, J.M., Twamley, E.W., McKibbin, C.L., Heaton, R.K., & Patterson, T.L. (2008). Subjective and objective quality of life in schizophrenia. Schizophrenia Research, 98, 201-208.

5) Buckley, P.F., Miller, B.J., Lehrer, D.S., & Castle, D.J. (2009). Psychiatric comorbidities and schizophrenia. Schizophrenia Bulletin, 35, 383-402.

6) Seeman, M.V. (2014). Eating disorders and psychosis: Seven hypotheses. World Journal of Psychiatry, 4, 112-119. doi: 10.5498/wjp.v4.i4.112.

7) Kouidrat, Y., Amad, A., Lalau, J.D., & Loas, G. (2014). Eating disorders in schizophrenia: Implications for research and management. Schizophrenia, 2014.

8) Solmi, F., Melamed, D., Lewis, G., & Kirkbridge, J.B. (2018). Longitudinal associations between psychotic experiences and disordered eating behaviours in adolescence: A UK population-based study. Lancet Child & Adolescent Health, 2, 591-599. S2352-4642(18)30180-9.

9) Ganson, K.T., Cuccolo, K., & Nagata, J.M. (2022). Associations between psychosis symptoms and eating disorders among a national sample of US college students. Eating Behaviors, 45.

10) Khalil, R.B., Hachem, D., & Richa, S. (2011). Eating disorders and schizophrenia in male patients: A review. Eating and Weight Disorders, 16, 150-156. doi: 10.1007/BF03325126.

11) George, M., Maheshwari, S., Chandran, S., Manohar, J., & Sathyanarayana Rao, T.S. (2017). Understanding the schizophrenia prodrome. Indian Journal of Psychiatry, 59, 505-509. doi: 10.4103/psychiatry.IndianJPsychiatry_464_17.

12) Silberg, J.L., & Bulik, C.M. (2005). The developmental association between eating disorders symptoms and symptoms of depression and anxiety in juvenile twin girls. Journal of Child Psychology and Psychiatry, 46, 1317-1326.

13) Malaspina, D., Walsh-Messinger, J., Brunner, A., Rahman, N., Corcoran, C., Kimhy, D.,...& Goldman, S.B. (2019). Features of schizophrenia following premorbid eating disorders. Psychiatry Research, 278, 275-280.

14) Sakson-Obada, O., Chudzikiewicz, P., Pankowski, D., & Jarema, M. (2018). Body image and body experience disturbances in schizophrenia: An attempt to introduce the concept of body self as a conceptual framework. Current Psychology, 37, 390-400. doi: 10.1007/s12144-016-9526-z.

15) Solmi, F., Mascarell, M.C., Zammit, S., Kirkbridge, J.B., & Lewis, G. (2019). Polygenic risk for schizophrenia, disordered eating behaviours, and body mass index in adolescents. The British Journal of Psychiatry, 215, 428-433. doi: 10.1192/bjp.2019.39.

16) Gratacòs, M., González, J.R., Mercader, J.M., de Cid, R., Urretavizcaya, M., & Estivill, X. (2007). Brain-derived neurotrophic factor Val66Met and psychiatric disorders: Meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biological Psychiatry, 61, P911-922. doi:

17) Ripke, S., Neale, B.M., Corvin, A., Walters, J., Farh, K.H., Holmans, P.A.,...& O'Donovan, M.C. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511, 412-427. doi: 10.1038/nature13595.

18) Trace, S.E., Baker, J.H., Peñas-Lledó, E., & Bulik, C.M. (2013). The genetics of eating disorders. Annual Review of Clinical Psychology, 9, 589-620.

19) Stahl, S.M. (2018). Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: Dopamine, serotonin, and glutamate. CNS Spectrums, 23, 187-191.

20) Haddad, P.M., & Correll, C.U. (2018). The acute efficacy of antipsychotics in schizophrenia: A review of recent meta-analyses. Therapeutic Advances in Psychopharmacology, 8, 303-318. doi:10.1177/2045125318781475.

21) Davis, J.M., Chen, N., & Glick, I.D. (2003). A meta-analysis of the efficacy of second-generation antipsychotics. Archives of General Psychiatry, 60, 553-564. doi:10.1001/archpsyc.60.6.553.

22) Mutwalli, H., Keeler, J.L., Bektas, S., Dhopatkar, N., Treasure, J., & Himmerich, H. (2023). Journal of Psychiatric Research, 160, 137-162.

23) Teff, K.L., & Kim, S.F. (2011). Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism. Physiology & Behavior, 104, 590-598.

24) Cuerda, C., Velasco, C., Merchán-Naranjo, J., García-Peris, P., & Arango, C. (2014). The effects of second-generation antipsychotics on food intake, resting energy expenditure, and physical activity. European Journal of Clinical Nutrition, 68, 146-152.

25) de Beaurepaire, R. (2021). Binge eating disorders in antipsychotic-treated patients with schizophrenia: Prevalence, antipsychotic specificities, and changes over time. Journal of Clinical Psychopharmacology, 41, 114-120. doi: 10.1097/JCP.0000000000001357.

26) Kluge, M., Schuld, A., Himmerich, H., Dalal, M., Schacht, A., Wehmeier, A.,...& Pollmächer, T. (2007). Clozapine and olanzapine are associated with food craving and binge eating: Results from a randomized double-blind study. Journal of Clinical Psychopharmacology, 27, 662-666. doi: 10.1097/jcp.0b013e31815a8872

27) Miron, I.C., Baroanā, V.C., Popescu, F., & Ionicā, F. (2014). Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders. Current Health Sciences Journal, 40, 12-17. doi: 10.12865/CHSJ.40.01.02.

28) Lord, C.C., Wyler, S.C., Wan, R., Castorena, C.M., Ahmed, N., Mathew, D.,...& Elmquist, J.K. (2017). The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C. Journal of Clinical Investigation, 127, 3402-3406. doi: 10.12865/CHSJ.40.01.02.

29) Elman, I., Borsook, D., & Lukas, S.E. (2006). Food intake and reward mechanisms in patients with schizophrenia: Implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology, 31, 2091-2120.

More from Melinda Karth M.S., M.A.
More from Psychology Today